GENEVA, Sept. 24 -- JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. filed a patent application (CN2026/084453) for “PHARMACEUTICAL COMPOSITION COMPRISING ANTI-HER3/MET ANTIBODY-DRUG CONJUGATE AND USE THEREOF”. With publication no. WO/2026/194976, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 47/68
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....